Top Clinical Trials companies in Brazil by EBIT Margin

This ranking features the top 2 Clinical Trials companies in Brazil ranked by EBIT Margin, averaging a EBIT Margin of 4.95%, for February 08, 2025.

Brazil

Clinical Trials
EBIT Margin
#
Name
EBIT Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
DASA3.SA

Diagnósticos da América S.A.

1

DASA3.SA
6.40%
Dec. 31, 2023 USD 0.31 -3.93%

Brazil
2
AALR3.SA

Centro de Imagem Diagnósticos S.A.

2

AALR3.SA
3.51%
Dec. 31, 2023 USD 1.75 -1.08%

Brazil
Frequently Asked Questions
  • Which Clinical Trials company in Brazil has the highest EBIT Margin ?

    The Clinical Trials company in Brazil with the highest EBIT Margin is Diagnósticos da América S.A. (São Paulo Stock Exchange: DASA3.SA) at 6.40%.

  • Which Clinical Trials company in Brazil has the lowest EBIT Margin ?

    The Clinical Trials company in Brazil with the lowest EBIT Margin is Centro de Imagem Diagnósticos S.A. (São Paulo Stock Exchange: AALR3.SA) at 3.51%.

SV Wall Street